GX-03 — Topline data
Q4 2026
Q4 2026: Topline ReadoutSource filing
TURN THERAPEUTICS INC · Data as of 2026-09-08
Q4 2026
Q4 2026: Topline ReadoutSource filing
Q4 2026
Q4 2026: FDA Type B MeetingSource filing
Q4-2027
Phase 3 readout from Eczema Q4-2027Source filing
Q1-2028
Interim Assessment from Phase 3 Onychomycosis Q1-2028Source filing